Proteineer
- Company typePrivate
- Founded2022
- HeadquartersDietzenbach, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
Proteineer firmographics
Firmographics- Name
- Proteineer
- Legal name
- Proteineer GmbH
- Website
- https://proteineer.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Proteineer industry classification
Industry- Product category
- AI-Driven Protein Engineering Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)
- akta.pro secondary industry
- Engineered Protein Therapeutics (de novo/AI-designed proteins, novel scaffolds) (HLAAAAAJ)
Keywords
Where Proteineer is headquartered
LocationHeadquarters
- HQ city
- Dietzenbach
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Proteineer business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- AI Software Services: Software services powered by proprietary AI algorithms for protein and enzyme engineering, likely offered on a project or subscription basis targeting biotech and pharmaceutical companies.
- Wet Lab Services: Experimental laboratory services complementing the AI software, providing end-to-end protein engineering from computational design to physical wet lab validation and testing.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Proteineer product offering
Product offeringCore offering
Proteineer offers AI-driven enzyme engineering and protein engineering expertise delivered as a combined software and wet lab service. The company uses AI to design proteins and enzymes and then validates them in its own laboratory, helping customers in diagnostics, therapeutics, and bio-design accelerate time to market for engineered biological molecules.
Product overview
Proteineer offers a unified AI-driven protein engineering and enzyme engineering platform. The company's core offering combines software services and wet lab services to accelerate the development of next-generation diagnostics, therapeutics, and bio-designed products. While the portfolio appears to be delivered as an integrated service offering rather than distinct modular products, the company positions its software and wet lab capabilities as complementary services within a single cohesive value proposition.
Differentiator
Problem solved
Functional benefit
Companies that use Proteineer
Customer profileSegments3 records
Ideal customer profiles3 records
Proteineer technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature1 record
Proteineer partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Expansion highlights3 records
Proteineer competitors and assessment
Company assessmentBroad incumbents
- Absci: Absci is a publicly listed AI biologics company combining generative AI with a wet-lab platform for antibody and protein drug discovery. Overlaps with Proteineer's AI-driven protein engineering focus on therapeutics.
- Insilico Medicine: Insilico Medicine applies AI across drug discovery, including target discovery and molecule design. A broader incumbent whose AI-driven biology platform overlaps thematically with Proteineer's engineering focus.
Direct peers
- BigHat Biosciences: BigHat Biosciences uses AI/ML with a wet-lab design cycle to engineer antibodies and other proteins. Directly comparable in combining AI protein design with experimental validation.
- Cradle: Cradle offers an AI-driven protein engineering platform serving biotech and industrial biology customers. It is the closest direct competitor to Proteineer's AI + wet-lab protein engineering value proposition.
- Generate Biomedicines: Generate Biomedicines is a generative biology company designing novel protein therapeutics with AI. Comparable to Proteineer's AI-engineered protein work targeting therapeutics customers.
- Profluent: Profluent develops AI models for protein design, including generative foundation models for novel proteins. It competes with Proteineer in AI-driven protein engineering for therapeutics and industrial applications.
- Cyrus Biotechnology: Cyrus Biotechnology offers protein engineering software and services, including computationally designed proteins and enzymes. Comparable to Proteineer in combining protein design tools with custom engineering services.
- LabGenius: LabGenius combines machine learning with automated wet-lab experimentation to engineer protein therapeutics. Closely comparable to Proteineer in the AI-guided protein engineering approach.
Emerging players
- EvolutionaryScale: EvolutionaryScale builds frontier AI foundation models for biology, including protein design. Comparable in leveraging large generative models for protein engineering though more upstream in the stack.
Others
- Biorelate: Biorelate provides AI-driven biomedical knowledge curation and target intelligence. Adjacent enabling technology that supports biotech R&D workflows similar to those served by Proteineer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Proteineer social profiles
Digital presenceProteineer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Proteineer leadership team
Management profileNumber of profiles
Profiles1 record
Proteineer funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Proteineer M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Proteineer
What does Proteineer do?
Proteineer offers AI-driven enzyme engineering and protein engineering expertise delivered as a combined software and wet lab service. The company uses AI to design proteins and enzymes and then validates them in its own laboratory, helping customers in diagnostics, therapeutics, and bio-design accelerate time to market for engineered biological molecules.
Is Proteineer a public or private company?
Proteineer is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Proteineer founded?
Proteineer was founded in 2022. It employs 1 to 10 people.
Where is Proteineer based?
Proteineer is headquartered in Dietzenbach, Germany, in the Europe region.
How does Proteineer make money?
Two revenue lines are on record. AI Software Services are the primary driver. The others are wet Lab Services.
Who are Proteineer's main competitors?
Broad incumbents on record are Absci and Insilico Medicine. Direct peers are BigHat Biosciences, Cradle, Generate Biomedicines, Profluent, Cyrus Biotechnology and LabGenius. EvolutionaryScale is listed as an emerging player. Biorelate is listed as an others.
Does Proteineer have an API?
No public API is recorded for Proteineer.
What industry is Proteineer in?
Proteineer's product category is AI-Driven Protein Engineering Services. Its primary akta.pro industry code is HLAAAIAC, Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization), with a secondary code of HLAAAAAJ, Engineered Protein Therapeutics (de novo/AI-designed proteins, novel scaffolds). Its NAICS code is 541714 and its SIC code is 8731.